C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2011
10/06/2011	US20110243978 Enterococcus antigens
10/06/2011	US20110243976 Compositions comprising pneumococcal antigens
10/06/2011	US20110243974 Novel tumor antigen protein sart-3 and tumor antigen peptides thereof
10/06/2011	US20110243967 Molecular complexes which modify immune responses
10/06/2011	US20110243960 Methods and compositions for treating p. acnes
10/06/2011	US20110243950 Msp2 antigenic peptides and their use
10/06/2011	US20110243945 Anti-Inflammatory Agents
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243923 Organic compounds
10/06/2011	US20110243914 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/06/2011	US20110243912 Growth Factor Binding Constructs Materials and Methods
10/06/2011	US20110243910 mammalian rna dependent rna polymerase
10/06/2011	US20110243906 Strain of highly mosquitocidal bacillus
10/06/2011	US20110243899 Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein
10/06/2011	US20110243888 Il-29 mutants and uses thereof
10/06/2011	US20110243887 Il-7 fusion proteins
10/06/2011	US20110243849 Heme-binding photoactive polypeptides and methods of use thereof
10/06/2011	US20110243845 Somatostatin analogs with inhibitory activity to growth hormone release
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	CA2795093A1 Immunogenic proteins and compositions
10/06/2011	CA2795043A1 Humanized il-25 antibodies
10/06/2011	CA2794930A1 Method for inhibiting hiv replication in mammal and human cells
10/06/2011	CA2794740A1 Methods for g-csf production in a pseudomonas host cell
10/06/2011	CA2794674A1 Frizzled-binding agents and uses thereof
10/06/2011	CA2794318A1 Method of enhancing the seed yield and promoting the growth of plants
10/06/2011	CA2794305A1 Compositions and methods for the removal of biofilms
10/06/2011	CA2793919A1 Fertilization prediction and promotion
10/06/2011	CA2793794A1 Tools for the identification of lingo-1, lingo-2, lingo-3 and lingo-4, ligands, and uses thereof
10/06/2011	CA2793143A1 Process for the purification of a growth factor protein
10/06/2011	CA2792537A1 Influenza virus vaccines and uses thereof
10/06/2011	CA2792174A1 Pharmaceutical compositions comprising a polypeptide comprising at least one cxxc motif and heterologous antigens and uses thereof
10/06/2011	CA2790186A1 Separation of insoluble target proteins
10/06/2011	CA2698413A1 Rotavirus vaccine
10/05/2011	EP2371966A1 Recombinant lentiviral vector for expression of a Flaviviridae protein and applications thereof as a vaccine
10/05/2011	EP2371965A1 Plants with increased expression of F-box WD40 polypeptide having increased yield and a method for making the same
10/05/2011	EP2371962A2 Receptor activator of NF-KAPPA B, receptor is member of TNF receptor superfamily
10/05/2011	EP2371959A2 Treatment of neurodegenerative disease through intracranial delivery of siRNA
10/05/2011	EP2371955A1 Integrase cofactor
10/05/2011	EP2371954A1 Compositions and methods for short interfering nucleic acid inhibition of NAv1.8
10/05/2011	EP2371953A1 Fluorescent protein
10/05/2011	EP2371858A2 Human-Murine chimeric antibodies against respiratory syncytial virus
10/05/2011	EP2371857A1 Factor XII inhibitors for treating interstitial lung disease
10/05/2011	EP2371856A2 Site-directed modification of FVIII
10/05/2011	EP2371855A1 Tissue protective peptides and uses thereof
10/05/2011	EP2371854A2 Induction of tumor immunity by variants of folate binding protein
10/05/2011	EP2371853A2 Insulin derivatives or its pharmaceutically acceptable salt, pharmaceutical composition, use of insulin derivative or its pharmaceutically acceptable salt and method of treatment
10/05/2011	EP2371852A2 Epitope analogues
10/05/2011	EP2371851A2 Epitope analogues
10/05/2011	EP2371850A2 Epitope analogues
10/05/2011	EP2371849A1 Differential in tumour gene products and use of same
10/05/2011	EP2371848A1 Differential in tumour gene products and use of same
10/05/2011	EP2371847A1 Peptides and their derived type APL of the HSP60 and pharmaceutical compositions
10/05/2011	EP2371846A1 Voltage dependent anion channel (vdac1) compositions and methods of use thereof for regulating apoptosis
10/05/2011	EP2371845A1 Plants having enhanced yield-related traits and a method for making the same
10/05/2011	EP2371844A1 Chimeric surface active proteins
10/05/2011	EP2371843A1 Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof
10/05/2011	EP2371842A1 Modified bacteriocins and methods for their use
10/05/2011	EP2371841A1 Methods for enhancing stress tolerance in plants and compositions thereof
10/05/2011	EP2371840A1 Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes
10/05/2011	EP2371839A1 Peptidomimetic protease inhibitors
10/05/2011	EP2371838A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371837A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371836A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/05/2011	EP2371391A1 Therapeutic use of anti-CS1 antibodies
10/05/2011	EP2371380A1 MVA expressing modified hiv envelope, gag, and pol genes
10/05/2011	EP2371377A1 Wound healing agent and composition
10/05/2011	EP2370817A2 Identification of porcine reproductive and respiratory syndrome virus
10/05/2011	EP2370574A1 Mutants of staphylokinase carrying amino and carboxy-terminal extensions for polyethylene glycol conjugation
10/05/2011	EP2370567A1 Novel method for generation of rna virus
10/05/2011	EP2370473A2 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
10/05/2011	EP2370472A1 Leptin and leptin analog conjugates and uses thereof
10/05/2011	EP2370471A1 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/05/2011	EP2370470A1 Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins
10/05/2011	EP2370463A2 Variants of activin iib receptor polypeptides and uses thereof
10/05/2011	EP2370462A1 Glucagon analogues
10/05/2011	EP2370461A1 Glucagon analogues
10/05/2011	EP2370460A1 Glucagon analogues
10/05/2011	EP2370459A1 Glucagon analogues
10/05/2011	EP2370458A1 Neuregulin peptides and their use
10/05/2011	EP2370457A2 Compositions and methods using alpha beta-crystallin in protecting the myocardium from ischemia/reperfusion injury
10/05/2011	EP2370456A1 Expression cassettes for seed-specific expression in plants
10/05/2011	EP2370455A2 Virus like particle compositions and methods of use
10/05/2011	EP2370107A2 Selective anticancer chimeric peptide
10/05/2011	EP2370104A1 Peptides for treatment of obesity
10/05/2011	EP2370101A1 Use of flt3 ligand for strengthening immune responses in rna immunization
10/05/2011	EP2370060A2 Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations
10/05/2011	EP2369910A1 Methods and compositions for the improvement of plant tolerance to environmental stresses
10/05/2011	EP2231860B1 Polypeptide derived from protein a and able to bind pdgf
10/05/2011	EP1971684B1 Chimaeric fusion protein with superior chaperone and folding activities
10/05/2011	EP1964918B1 Protein which can serve as nucleus for polymerization of protein polymer and process for production of cells comprising said nucleus
10/05/2011	EP1934353B1 IL-15R alpha sushi domains as a selective and potent enahncer of IL-15 action though IL-15Rbeta/gamma , in hyperagonist IL-15 Ralpha sushi -IL 15 fusion proteins .
10/05/2011	EP1848804B1 Anti-muc1 alpha beta antibodies
10/05/2011	EP1802778B1 Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof
10/05/2011	EP1784416B1 Vaccines against aids comprising cmv/r nucleic acid constructs
10/05/2011	EP1731610B1 Proteins imparting boron-tolerance and genes thereof
10/05/2011	EP1711604B1 Diabetogenic epitopes
10/05/2011	EP1678310B1 Axmi-010, a delta-endotoxin gene and methods for its use
10/05/2011	EP1530639B1 Polypeptides comprising a modified human serum albumin secretion pre-sequence with improved secretion yield
10/05/2011	EP1495115B1 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy
10/05/2011	EP1492814B1 Interleukin-1-beta derived peptide and its therapeutic application

1 ... 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 ... 2916